Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Sell
582
-16,750
-97% -$3.04M ﹤0.01% 2364
2026
Q1
$2.66M Sell
17,332
-4,335
-20% -$588K 0.01% 1227
2025
Q4
$2.46M Buy
21,667
+11,286
+109% +$1.37M ﹤0.01% 1324
2025
Q3
$1.38M Buy
10,381
+7,012
+208% +$963K ﹤0.01% 1696
2025
Q2
$480K Sell
3,369
-11,339
-77% -$1.61M ﹤0.01% 2139
2025
Q1
$2.25M Sell
14,708
-2,396
-14% -$376K 0.01% 1357
2024
Q4
$2.56M Buy
+17,104
New +$2.68M 0.01% 1275

Other funds holding DVA

PEAK6's DVA Position: Q2 2026 in Review

PEAK6 reduced its DaVita (DVA) stake by 97% in Q2 2026, selling an estimated $3.04M and leaving 582 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

PEAK6 first reported a position in DVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.66M in Q1 2026. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • PEAK6 held 582 shares of DaVita worth $129K as of Q2 2026.
  • PEAK6 sold 16,750 DaVita shares in Q2 2026, an estimated $3.04M.
  • DaVita made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2364 holding.
  • PEAK6 first reported a position in DaVita in Q4 2024 and has held it in 7 quarters since.
  • PEAK6's DaVita position peaked at $2.66M in Q1 2026.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.